| Literature DB >> 30146260 |
Yukiko Yasuoka1, Yuichiro Izumi2, Takanori Nagai3, Takashi Fukuyama4, Yushi Nakayama2, Hideki Inoue2, Kahori Horikawa3, Miho Kimura3, Masayoshi Nanami3, Kengo Yanagita5, Tomomi Oshima1, Taiga Yamazaki4, Takayuki Uematsu4, Rui Yamamura4, Noritada Kobayashi4, Yoshitaka Shimada6, Yasushi Nagaba6, Takeshi Nakanishi3, Tetsuro Yamashita7, Masashi Mukoyama2, Yuichi Sato5, Katsumasa Kawahara1, Hiroshi Nonoguchi8.
Abstract
Erythropoietin has been thought to be secreted to plasma soon after the production because of the difficulty of Western blot analysis and immunohistochemistry. We established the new methods of Western blot analysis and immunohistochemistry. Using the new methods, we investigated the effects of aldosterone and fludrocortisone, an analogue of aldosterone on erythropoietin mRNA and protein production by the kidneys. Aldosterone stimulated Epo and HIF2α mRNA expressions in tubule suspensions and microdissected medullary thick ascending limbs and outer medullary collecting ducts. Western blot analysis showed a recombinant erythropoietin at 34-45 kDa and kidney erythropoietin at 36-40 and 42 kDa, both of which shifted to 22 kDa by deglycosylation. Erythropoietin protein expression was observed in the nephrons but not in the interstitial cells in control condition. Fludrocortisone stimulated erythropoietin mRNA and protein expressions in the distal nephrons, particularly in the intercalated cells of the collecting ducts. These data show that erythropoietin is produced by the nephrons by the regulation of renin-angiotensin-aldosterone system and not by the renal interstitial cells in control condition.Entities:
Keywords: Collecting ducts; Deglycosylation; Erythropoietin; Hypoxia; Interstitial cells; Renin-angiotensin-aldosterone system
Mesh:
Substances:
Year: 2018 PMID: 30146260 DOI: 10.1016/j.bbrc.2018.08.102
Source DB: PubMed Journal: Biochem Biophys Res Commun ISSN: 0006-291X Impact factor: 3.575